ScholarIQanswers from OpenAlex & ORCID
Desmond Schatz
ResearcherPublications, citations & collaboration network
Desmond Schatz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Desmond Schatz have?
ScholarIQindexed works
Desmond Schatz has 542 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Desmond Schatz have?
ScholarIQcitation count
Desmond Schatz has 37,245 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Desmond Schatz?
ScholarIQh-index
Desmond Schatz has an h-index of 92 in OpenAlex.
What is the i10-index of Desmond Schatz?
ScholarIQi10-index
Desmond Schatz has an i10-index of 299 in OpenAlex.
What is the ORCID of Desmond Schatz?
ScholarIQorcid
The ORCID for Desmond Schatz is on the source record.
What is the OpenAlex record for Desmond Schatz?
ScholarIQopenalex
The OpenAlex for Desmond Schatz is on the source record.
What are the most-cited papers on Desmond Schatz?
ScholarIQmost cited works
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino, Thomas Danne, Richard M. Bergenstal, Stephanie A. Amiel, Roy W. Beck, Torben Biester, Emanuele Bosi, Bruce A. Buckingham, William T. Cefalu, Kelly L. Close, Claudio Cobelli, Eyal Dassau, J. Hans DeVries, Kim C. Donaghue, Klemen Dovč, Francis J. Doyle, Satish K. Garg, George Grunberger, Simon Heller, Lutz Heinemann, Irl B. Hirsch, Roman Hovorka, Weiping Jia, Olga Kordonouri, Boris Kovatchev, Aaron J. Kowalski, Lori M. Laffel, Brian J. Levine, Alexander Yur'evich Mayorov, Chantal Mathieu, Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Richard A. Insel, Jessica L. Dunne, Mark A. Atkinson, Jane L. Chiang, Dana Dabelea, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jeffrey P. Krischer, Åke Lernmark, Robert E. Ratner, Marian Rewers, Desmond Schatz, Jay S. Skyler, Jay M. Sosenko, Anette‐G. Ziegler
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Paula McGee, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, John M. Lachin, Jay S. Skyler
Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
Jay S. Skyler, George L. Bakris, Ezio Bonifacio, Tamara Darsow, Robert H. Eckel, Leif Groop, Per‐Henrik Groop, Yehuda Handelsman, Richard A. Insel, Chantal Mathieu, Allison T. McElvaine, Jerry P. Palmer, Alberto Pugliese, Desmond Schatz, Jay M. Sosenko, John Wilding, Robert E. Ratner